Medtronic, NuVasive, InVivo Therapeutics & more: 6 device company notes

Written by Anuja Vaidya | September 01, 2017 | Print  | Email

Here are six key notes on orthopedic and spine device companies from the past week.

Medtronic will enter into the next phase of its strategic partnership with Mazor Robotics, making a third investment in the company.


Medtronic CEO Omar Ishrak received $15.7 million in compensation for the 2017 fiscal year.


InVivo Therapeutics eliminated 13 positions in a quest to focus attention on the Inspire Study and earn an FDA humanitarian device exemption for the Neuro-Spinal Scaffold.


NuVasive plans to expand its San Diego-based headquarters and add an innovation center to the facility.


MicroPort Orthopedics launched its Procotyl Prime Acetabular Cup System for hip replacement surgery.


Anika Therapeutics, a global orthopedic medicines company, elected Steven Chartier to vice president of regulatory and clinical affairs.


More articles on devices:
Spine implant segment leads global orthopedic device market: 6 observations
6 key quotes from CEO Omar Ishrak during Medtronic's Q1 earnings call
20 spine devices receive FDA 510(k) clearances in July

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.